Article révisé par les pairs
Titre:
  • Optimizing taxane use in MBC in the emerging era of targeted chemotherapy
Auteur:Von Minckwitz, Gunter; Martin, Miguel; Wilson, Gregory G.J.; Alba, Emilio; Schmidt, Marcus; Biganzoli, Laura; Awada, Ahmad
Informations sur la publication:Critical reviews in oncology/hematology, 85, 3, page (315-331)
Statut de publication:Publié, 2013-03
Sujet CREF:Cancérologie
Hématologie
Gériatrie - gérontologie
Mots-clés:Biomarkers
Breast cancer
Metastatic
Paclitaxel albumin
SPARC
Taxane
MeSH keywords:Antineoplastic Agents -- administration & dosage -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms -- drug therapy -- mortality -- pathology
Bridged Compounds -- administration & dosage -- therapeutic use
Clinical Trials as Topic
Female
Humans
Molecular Targeted Therapy
Neoplasm Metastasis
Taxoids -- administration & dosage -- therapeutic use
Treatment Outcome
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1040-8428
info:doi/10.1016/j.critrevonc.2012.09.009
info:pii/S1040842812001928
info:scp/84873525763
info:pmid/23116625